General Pharmacology: The Vascular System 1999-07-01

Binding affinity of sarpogrelate to 5-HT(2A) receptor ligand recognition sites in rat renal cortical and mesangial cells in culture.

H Nishio, S Yoshikawa, Y Morimoto, Z Chen, Y Nakata

Index: Gen. Pharmacol. 33(1) , 51-7, (1999)

Full Text: HTML

Abstract

We detected specific binding of 3H-ketanserin (0.6 nM) in rat renal cortical membrane preparations (4.70 +/- 0.57 fmol/mg protein) and mesangial cells (7.55 +/- 0.92 fmole/10(6) cells). Thus, the value in the renal cortical membrane corresponded to 15% of that in the cerebral cortical membranes (30.0 +/- 2.9 fmole/mg protein). The affinity of 3H-ketanserin binding displacement activities by sarpogrelate, a selective 5-HT2A receptor antagonist, in the renal cortical membrane (IC50; 0.448 +/- 0.061 microM) and mesangial cells (IC50; 0.656 +/- 0.187 microM) were almost 100-fold less than that in the cerebral cortical membrane (IC50; 4.62 +/- 1.02 nM). In the renal cortical membranes and mesangial cells, methysergide displaced a tiny fraction of 3H-ketanserin binding at concentrations up to 10 microM. These results did not explain the functional activity of 5-HT in the mesangial cells, and we conclude that specific 3H-ketanserin binding sites in the mesangial cells consisted of methysergide-resistant and non-serotonergic sites with low affinity for sarpogrelate.


Related Compounds

Related Articles:

Protracted effects of chronic stress on serotonin-dependent thermoregulation.

2015-01-01

[Stress 18 , 668-76, (2015)]

Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.

2004-11-18

[J. Med. Chem. 47(24) , 6034-41, (2004)]

A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes.

2005-03-10

[Forensic Sci. Int. 148(2-3) , 131-7, (2005)]

In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites.

2002-03-01

[J. Anal. Toxicol. 26(2) , 61-6, (2002)]

2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.

2008-12-15

[Toxicol. Lett. 183(1-3) , 52-7, (2008)]

More Articles...